The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: a single institutional survey

The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: a single institutional survey

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology Vol. 1; no. 5; p. 501
Main Authors: Velcheti, Vamsidhar, Viswanathan, Avinash, Govindan, Ramaswamy
Format: Journal Article
Language:English
Published: United States 01-06-2006
Subjects:
Angiogenesis Inhibitors - therapeutic use
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Bevacizumab
Carcinoma, Non-Small-Cell Lung - drug therapy
Humans
Lung Neoplasms - drug therapy
Neoplasm Metastasis
Retrospective Studies
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1556-1380
DOI:10.1097/01243894-200606000-00023